Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2000 4
2001 1
2002 3
2003 2
2004 6
2005 10
2006 12
2007 8
2008 16
2009 13
2010 11
2011 11
2012 5
2013 3
2014 1
2015 4
2016 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.
Dennis M, Sandercock P, Graham C, Forbes J; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration; Smith J. Dennis M, et al. Health Technol Assess. 2015 Sep;19(76):1-90. doi: 10.3310/hta19760. Health Technol Assess. 2015. PMID: 26418530 Free PMC article. Clinical Trial.
Bis(1,3-dibenzyl-imidazolium) μ-oxido-bis-[trichloridoferrate(III)].
Mutambi EM, Adams CJ, Orpen AG. Mutambi EM, et al. Among authors: orpen ag. Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 26;66(Pt 7):m846. doi: 10.1107/S1600536810024098. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21587757 Free PMC article.
Exploring threats to generalisability in a large international rehabilitation trial (AVERT).
Bernhardt J, Raffelt A, Churilov L, Lindley RI, Speare S, Ancliffe J, Katijjahbe MA, Hameed S, Lennon S, McRae A, Tan D, Quiney J, Williamson HC, Collier J, Dewey HM, Donnan GA, Langhorne P, Thrift AG; AVERT Trialists’ Collaboration. Bernhardt J, et al. BMJ Open. 2015 Aug 17;5(8):e008378. doi: 10.1136/bmjopen-2015-008378. BMJ Open. 2015. PMID: 26283667 Free PMC article. Clinical Trial.
cis-Aqua-dichlorido[pyrimidin-2(1H)-one-κN]copper(II).
Kurawa MA, Adams CJ, Orpen AG. Kurawa MA, et al. Among authors: orpen ag. Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 28;64(Pt 7):m969. doi: 10.1107/S1600536808018771. Acta Crystallogr Sect E Struct Rep Online. 2008. PMID: 21202815 Free PMC article.
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Bernhardt J, Churilov L, Ellery F, Collier J, Chamberlain J, Langhorne P, Lindley RI, Moodie M, Dewey H, Thrift AG, Donnan G; AVERT Collaboration Group. Bernhardt J, et al. Neurology. 2016 Jun 7;86(23):2138-45. doi: 10.1212/WNL.0000000000002459. Epub 2016 Feb 17. Neurology. 2016. PMID: 26888985 Free PMC article. Clinical Trial.
Nanoporous organic alloys.
Natarajan R, Magro G, Bridgland LN, Sirikulkajorn A, Narayanan S, Ryan LE, Haddow MF, Orpen AG, Charmant JP, Hudson AJ, Davis AP. Natarajan R, et al. Among authors: orpen ag. Angew Chem Int Ed Engl. 2011 Nov 25;50(48):11386-90. doi: 10.1002/anie.201105216. Epub 2011 Oct 4. Angew Chem Int Ed Engl. 2011. PMID: 21976397 No abstract available.
Statistical modeling of a ligand knowledge base.
Mansson RA, Welsh AH, Fey N, Orpen AG. Mansson RA, et al. Among authors: orpen ag. J Chem Inf Model. 2006 Nov-Dec;46(6):2591-600. doi: 10.1021/ci600212t. J Chem Inf Model. 2006. PMID: 17125199
A chemically functionalizable nanoporous material.
Chui SS, Lo SM, Charmant JP, Orpen AG, Williams ID. Chui SS, et al. Among authors: orpen ag. Science. 1999 Feb 19;283(5405):1148-50. doi: 10.1126/science.283.5405.1148. Science. 1999. PMID: 10024237
106 results